According to Adicet Bio's latest financial reports and stock price the company's current Operating Margin is -93.00%. At the end of 2021 the company had an Operating Margin of -638.48%.
Year | Operating Margin | Change |
---|---|---|
2021 | -638.48% | 189.44% |
2020 | -220.59% | -92.19% |
2019 | -2,826.03% | 2238.16% |
2018 | -120.87% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
Novartis NVS | 17.27% | -118.57% | ๐จ๐ญ Switzerland |
Pfizer PFE | 34.61% | -137.22% | ๐บ๐ธ USA |
Merck MRK | 27.73% | -129.82% | ๐บ๐ธ USA |
Teva Pharmaceutical Industries TEVA | -20.53% | -77.92% | ๐ฎ๐ฑ Israel |
Hawkins HWKN | 8.54% | -109.18% | ๐บ๐ธ USA |
Quaker Houghton KWR | 0.36% | -100.39% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.